137 related articles for article (PubMed ID: 4600926)
1. [Anxiety and its emotional sedation].
Pelicier Y
Therapeutique; 1973 Nov; 49(9):557-9. PubMed ID: 4600926
[No Abstract] [Full Text] [Related]
2. Evaluation of lorazepam as an anxiolytic agent in psychiatric practice.
Lasich AJ
S Afr Med J; 1974 Apr; 48(16):681-3. PubMed ID: 4823727
[No Abstract] [Full Text] [Related]
3. Clinical experience with lorazepam in the treatment of neurotic patients.
De Buck R
Curr Med Res Opin; 1973; 1(5):291-5. PubMed ID: 4589715
[No Abstract] [Full Text] [Related]
4. [Evaluation of the anti-anxiety activity of lorazepam in ambulatory patients].
Terra SO; Bueno JR; Pires LL
J Bras Psiquiatr; 1971; 20(3):237-47. PubMed ID: 4950635
[No Abstract] [Full Text] [Related]
5. [Results of clinical trial of Ro-4-6270 in depressive-anxiety states].
Ardito R; Paterni F
Riv Neurobiol; 1967; 13(1):3-10. PubMed ID: 5602736
[No Abstract] [Full Text] [Related]
6. Lorazepam in phobic disorders: a pilot study.
Silverstone JT
Curr Med Res Opin; 1973; 1(5):272-5. PubMed ID: 4589714
[No Abstract] [Full Text] [Related]
7. Recent developments in the use of antidepressant and anxiolytic medications.
Simeon JG; Ferguson HB
Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic treatment of anxiety disorders.
Mavissakalian M
J Clin Psychiatry; 1982 Dec; 43(12):487-91. PubMed ID: 6131065
[TBL] [Abstract][Full Text] [Related]
9. [Clinical and therapeutic considerations on the use of a benzodiazepine derivative, bromazepam (Ro 5-3350) in the treatment of obsessive-phobic disorders].
Salmoni G; Amati A; Giambelluca A; Vacca L
Acta Neurol (Napoli); 1973; 28(5):588-609. PubMed ID: 4789497
[No Abstract] [Full Text] [Related]
10. A comparison of lorazepam, diazepam and placebo in the treatment of anxiety states.
Singh AN; Saxena B
Curr Ther Res Clin Exp; 1974 Mar; 16(3):149-62. PubMed ID: 4206723
[No Abstract] [Full Text] [Related]
11. The effect of lorazepam on anxious insomniacs' sleep as recorded in the home environment.
Globus G; Phoebus E; Humphries J; Boyd R; Gaffney D; Gaffney S
J Clin Pharmacol; 1974 Apr; 14(4):192-201. PubMed ID: 4362996
[No Abstract] [Full Text] [Related]
12. Clinical experience with lorazepam in hospital patients.
Imlah NW
Curr Med Res Opin; 1973; 1(5):276-81. PubMed ID: 4773189
[No Abstract] [Full Text] [Related]
13. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
[TBL] [Abstract][Full Text] [Related]
14. Let's talk facts about anxiety disorders.
American Psychiatric Association
J Okla State Med Assoc; 2008 Dec; 101(12):347-50. PubMed ID: 19177997
[No Abstract] [Full Text] [Related]
15. Clinical trial of a new drug, analog of chlordiazepoxide, for treatment of anxiety and tension.
Gilbert MM
Int J Neuropsychiatry; 1965 Dec; 1(6):556-8. PubMed ID: 5886535
[No Abstract] [Full Text] [Related]
16. Clinical experiences with lorazepam in Japan.
Kudo Y
Curr Med Res Opin; 1973; 1(5):301. PubMed ID: 4773194
[No Abstract] [Full Text] [Related]
17. Clinical assessment of lorazepam in neurotic out-patients in Thailand.
Sudharatna Y; Sudharatna P
Curr Med Res Opin; 1973; 1(10):591-5. PubMed ID: 4778723
[No Abstract] [Full Text] [Related]
18. Clomipramine intravenous drip: treatment of obsessional and phobic anxiety states.
Marshall WK
Nurs Times; 1972 Nov; 68(46):1448-9. PubMed ID: 4635061
[No Abstract] [Full Text] [Related]
19. [Comparative clinical evaluation of lorazepam (author's transl)].
Padron C
Schweiz Rundsch Med Prax; 1974 Apr; 63(16):494-6. PubMed ID: 4597377
[No Abstract] [Full Text] [Related]
20. [A new benzodiazepine screened in a parallel double-blind test].
Lens F
Acta Psychiatr Belg; 1974 May; 74(3):327-37. PubMed ID: 4156150
[No Abstract] [Full Text] [Related]
[Next] [New Search]
